{
    "nctId": "NCT02150590",
    "officialTitle": "Patients With Chronic Obstructive Pulmonary Disease Staying at Altitude - Effect of Nocturnal Oxygen Therapy on Breathing and Sleep in",
    "inclusionCriteria": "* chronic obstructive pulmonary disease (COPD), GOLD grade 2-3\n* residents at low altitude (\\<800 m)\n* Must have minimum age of 18 Years\n* Must have maximum age of 75 Years",
    "exclusionCriteria": "* unstable condition, COPD exacerbation\n* mild (GOLD 1) or very severe COPD (GOLD 4)\n* requirement for oxygen therapy at low altitude residence\n* hypoventilation\n* pulmonary hypertension\n* more than mild or unstable cardiovascular disease\n* use of drugs that affect respiratory center drive\n* internal, neurologic or psychiatric disease that interfere with protocol compliance including current heavy smoking (\\>20 cigarettes per day), inability to perform 6 min walk test.\n* previous intolerance to moderate altitude (\\<2600m).\n* exposure to altitudes \\>1500m for \\>2 days within the last 4 weeks before the study.\n* pregnant or nursing patients"
}